文档介绍：关于英文摘要写法
第1页，讲稿共77张，创作于星期三
一、摘要的基本要素
定义：又称概要或内容提要。以提供文献实质性的内容梗概为主要目的，不加评论和补充解释，简明、确切地记述文献重要内容的短文。
目的：给读者关于文献内容的足)结构的写作模式。
20世纪80年代中期出现了另一种摘要文体，即“结构式摘要"(structured abstract),该摘要实质上是报道性摘要的结构化表达。
第13页，讲稿共77张，创作于星期三
SCI结构式摘要案例
目的、设计、单位、对象、处置、主要结果测定、结果、结论等8个方面
目的：研究的问题、目的或设想
设计：研究的基本设计、样本选择、分组、诊断标准和随访情况
单位：说明开展研究的单位（研究机构、大学、医疗机构）
对象：研究对象（患者等）的数目、选择过程和条件等
处置：处置方法的基本特征，使用何种方法以及持续的时间等
主要结果测定：主要结果是如何测定、完成的
结果：研究的主要发现（应给出确切的置信度和统计学显著检验值
结论：主要结论及潜在的临床应用
第14页，讲稿共77张，创作于星期三
SCI结构式摘要案例
Abstract: Context Patients experience the highest rate of death and recurrent ischemic events during the early period after an acute coronary syndrome, but it is not known whether early initiation of treatment with a statin can reduce the occurrence of these early events.
Objective To determine whether treatment with atorvastatin, 80 mg/d, initiated 24 to 96 hours after an acute coronary syndrome, reduces death and nonfatal ischemic events.
Design and Setting A randomized, double-blind trial conducted from May 1997 to September 1999, with follow-up through 16 weeks at 122 clinical centers in Europe, North America, South Africa, and Australasia.
Patients A total of 3086 adults aged 18 years or older with unstable angina or non-Q-wave acute myocardial infarction.
Interventions Patients were stratified by center and randomly assigned to receive treatment with atorvastatin (80 mg/d) or matching placebo between 24 and 96 hours after hospital admission.
Main Outcome Measures Primary end point event defined as death, nonfatal acute myocardial infarction, cardiac arrest with resuscitation, or recurrent symptomatic myocardial ischemia with objective evidence and requiring emergency rehospitalization.
Results A primary end point event occurred in 228 patients (%) in the atorvastatin group and 269 patients (%) in the placebo group (relative risk [RR], ; 95% confidence interval [CI], -; P = .048). There were no significant differences in risk of death, nonfatal myocardial